References
- Moeschler JB, Shevell M, the Committee on Genetics. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics. 2006;117(6):2304–e16. doi:https://doi.org/10.1542/peds.2006-1006.
- Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, Majnemer A, Noetzel M, Sheth RD, Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003;60(3):367–80. doi:https://doi.org/10.1212/01.wnl.0000031431.81555.16.
- Accardo P, Capute A. Intellectual disability. In: Oski F, Diangelis CD, editors. Principles and practice of pediatrics. Philadelphia, PA: Lippincott; 1995. p. 673–9.
- Schroeder SR, Gertz G, Velazquez F. Final project report: usage of the term ‘mental retardation’: language, image and public education. Lawrence, KS: University of Kansas, Center on Developmental Disabilities; 2002.
- Fan Y, Wu Y, Wang L, Wang Y, Gong Z, Qiu W, Wang J, Zhang H, Ji X, Ye J, et al. Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions. BMC Med Genomics. 2018;11(1):49. doi:https://doi.org/10.1186/s12920-018-0368-4.
- Lmal SH, Padh H. Implications of gene copy-number variation in health and diseases. J Hum Genet. 2012;57(1):6–13. doi:https://doi.org/10.1038/jhg.2011.108.
- Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–64. doi:https://doi.org/10.1016/j.ajhg.2010.04.006.
- Hochstenbach R, van Binsbergen E, Engelen J, Nieuwint A, Polstra A, Poddighe P, Ruivenkamp C, Sikkema-Raddatz B, Smeets D, Poot M. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet. 2009;52(4):161–9. doi:https://doi.org/10.1016/j.ejmg.2009.03.015.
- Moeschler JB, Shevell M, Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134(3):e903–18. doi:https://doi.org/10.1542/peds.2014-1839.
- Khelifa HB, Soyah N, Labalme A, Guilbert H, Sanlaville D, Saad A, Zerelli SM. Genomic microarray in intellectual disability: the usefulness of existing systems in the interpretation of copy number variation. J Pediatr Genet. 2017;6(2):84–91. doi:https://doi.org/10.1055/s-0036-1588027.
- Battaglia A, Doccini V, Bernardini L, Novelli A, Loddo S, Capalbo A, Filippi T, Carey JC. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol. 2013;17(6):589–99. doi:https://doi.org/10.1016/j.ejpn.2013.04.010.
- D’Arrigo S, Gavazzi F, Alfei E, Zuffardi O, Montomoli C, Corso B, Buzzi E, Sciacca FL, Bulgheroni S, Riva D, et al. The diagnostic yield of array comparative genomic hybridization is high regardless of severity of intellectual disability/developmental delay in children. J Child Neurol. 2016;31(6):691–9. doi:https://doi.org/10.1177/0883073815613562.
- Shoukier M, Klein N, Auber B, Wickert J, Schröder J, Zoll B, Burfeind P, Bartels I, Alsat EA, Lingen M, et al. Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants? Clin Genet. 2013;83(1):53–65. doi:https://doi.org/10.1111/j.1399-0004.2012.01850.x.
- Geng J, Picker J, Zheng Z, Zhang X, Wang J, Hisama F, Brown DW, Mullen MP, Harris D, Stoler J, et al. Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. BMC Genomics. 2014;15:1127. doi:https://doi.org/10.1186/1471-2164-15-1127.
- Caballero Perez V, Lopez Pison FJ, Miramar Gallart MD, Gonzalez Alvarez A, Garcia Jimenez MC, Garcia Iniguez JP, Orden Rueda C, Gil Hernandez I, Fuertes Rodrigo C, Fernando Martinez R, et al. Phenotype in patients with intellectual disability and pathological results in array CGH. Neurologia. 2017;32(9):568–78. doi:https://doi.org/10.1016/j.nrleng.2016.03.003.
- Oikonomakis V, Kosma K, Mitrakos A, Sofocleous C, Pervanidou P, Syrmou A, Pampanos A, Psoni S, Fryssira H, Kanavakis E, et al. Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications. Clin Genet. 2016;89(6):708–18. doi:https://doi.org/10.1111/cge.12740.
- Zahnleiter D, Uebe S, Ekici AB, Hoyer J, Wiesener A, Wieczorek D, Kunstmann E, Reis A, Doerr HG, Rauch A, et al. Rare copy number variants are a common cause of short stature. PLoS Genet. 2013;9(3):e1003365. doi:https://doi.org/10.1371/journal.pgen.1003365.
- Rice AM, McLysaght A. Dosage sensitivity is a major determinant of human copy number variant pathogenicity. Nat Commun. 2017;8:14366. doi:https://doi.org/10.1038/ncomms14366.
- Wayhelova M, Smetana J, Vallova V, Hladilkova E, Filkova H, Hanakova M, Vilemova M, Nikolova P, Gromesova B, Gaillyova R, et al. The clinical benefit of array based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay. BMC Med Genomics. 2019;12(1). doi:https://doi.org/10.1186/s12920-019-0559-7.
- Stankiewicz P, Pursley AN, Cheung SW. Challenges in clinical interpretation of microduplications detected by array CGH analysis. Am J Med Genet A. 2010;152A(5):1089–100. doi:https://doi.org/10.1002/ajmg.a.33216.
- Newman S, Hermetz KE, Weckselblatt B, Rudd MK. Next-generation sequencing of duplication CNVs reveals that most are tandem and some create fusion genes at breakpoints. Am J Hum Genet. 2015;96(2):208–20. doi:https://doi.org/10.1016/j.ajhg.2014.12.017.
- Friedman J, Adam S, Arbour L, Armstrong L, Baross A, Birch P, Boerkoel C, Chan S, Chai D, Delaney AD, et al. Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization. BMC Genomics. 2009;10(1):526. doi:https://doi.org/10.1186/1471-2164-10-526.
- Shaffer L, Theisen A, Bejjani B, Ballif B, Aylsworth A, Lim C, McDonald M, Ellison JW, Kostiner D, Saitta S, et al. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Genet Med. 2007;9(9):607–16. doi:https://doi.org/10.1097/gim.0b013e3181484b49.
- Watson C, Tomas M, Sharp A, Mefford H. The genetics of microdeletion and microduplication syndromes: an update. Annu Rev Genomics Hum Genet. 2014;15(1):215–44. doi:https://doi.org/10.1146/annurev-genom-091212-153408.
- Warburton D. De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. Am J Hum Genet. 1991;49(5):995–1013.
- Waters J, Campbell L, Crocker M, Campbell M. Phenotypic effects of balanced X-autosome translocations in females: a retrospective survey of 104 cases reported from UK laboratories. Hum Genet. 2001;108(4):318–27. doi:https://doi.org/10.1007/s004390100465.
- Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis. 2008;3(1). doi:https://doi.org/10.1186/1750-1172-3-30.
- Délot EC, Papp JC, Sandberg DE, Vilain E, DSD-TRN Genetics Workgroup. Genetics of disorders of sex development: the DSD-TRN experience. Endocrinol Metab Clin North Am. 2017;46(2):519–37. doi:https://doi.org/10.1016/j.ecl.2017.01.015.